Lansovil Kid Tablet DT contains Lansoprazole 15mg, a proton pump inhibitor indicated for the treatment of acid-related gastrointestinal conditions in pediatric patients. Lansoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. This formulation is designed as a dispersible tablet to facilitate ease of administration in children who may have difficulty swallowing conventional tablets. Lansovil Kid Tablet DT is primarily used for the management of gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease in the pediatric population. The rapid onset of acid suppression helps alleviate symptoms such as heartburn, regurgitation, and epigastric discomfort, promoting mucosal healing. The recommended dose and duration of therapy should be determined by a healthcare professional based on the severity of the condition and patient response. Lansoprazole is generally well tolerated; however, potential adverse effects may include headache, abdominal pain, diarrhea, and nausea. Caution is advised in patients with known hypersensitivity to lansoprazole or other proton pump inhibitors. Lansovil Kid Tablet DT should be used under medical supervision, ensuring adherence to prescribed dosing to optimize therapeutic outcomes and minimize risks.